Coloplast A/S banner

Coloplast A/S
OTC:CLPBF

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBF
Watchlist
Price: 66.5 USD Market Closed
Market Cap: $14.9B

P/B

6.7
Current
40%
Cheaper
vs 3-y average of 11

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
6.7
=
Market Cap
$108.7B
/
Total Equity
kr13.8B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
6.7
=
Market Cap
$108.7B
/
Total Equity
kr13.8B

Valuation Scenarios

Coloplast A/S is trading below its 3-year average

If P/B returns to its 3-Year Average (11), the stock would be worth $109.96 (65% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-66%
Maximum Upside
+216%
Average Upside
42%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 6.7 $66.5
0%
3-Year Average 11 $109.96
+65%
5-Year Average 21 $209.97
+216%
Industry Average 3.6 $35.49
-47%
Country Average 2.3 $22.76
-66%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close

Market Distribution

Lower than 85% of companies in Denmark
Percentile
15th
Based on 438 companies
15th percentile
1.1
Low
0.4 — 1.5
Typical Range
1.5 — 4.5
High
4.5 —
Distribution Statistics
Denmark
Min 0.4
30th Percentile 1.5
Median 2.3
70th Percentile 4.5
Max 44.6

Coloplast A/S
Glance View

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

CLPBF Intrinsic Value
111.32 USD
Undervaluation 40%
Intrinsic Value
Price $66.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett